Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Glaukos Corp (NY: GKOS ) 128.29 +0.81 (+0.64%) Official Closing Price Updated: 7:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Glaukos Corp < Previous 1 2 3 4 5 6 7 8 Next > Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 December 12, 2022 Via Benzinga Where Glaukos Stands With Analysts December 12, 2022 Via Benzinga Glaukos Announces Participation in the Stephens Annual Investment Conference November 07, 2022 From Glaukos Corporation Via Business Wire What 4 Analyst Ratings Have To Say About Glaukos November 03, 2022 Analysts have provided the following ratings for Glaukos (NYSE:GKOS) within the last quarter: Via Benzinga Needham Says Recent Launches To Drive Market Share Recovery For This Eye-Focused MedTech Stock October 04, 2022 Via Benzinga Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday November 04, 2022 U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session. Via Benzinga Glaukos Corporation Announces Third Quarter 2022 Financial Results November 02, 2022 From Glaukos Corporation Via Business Wire Glaukos to Release Third Quarter 2022 Financial Results after Market Close on November 2 October 12, 2022 From Glaukos Corporation Via Business Wire Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate September 07, 2022 Via Benzinga Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment August 24, 2022 Via Benzinga Glaukos Receives FDA 510(k) Clearance For iStent infinite August 03, 2022 The U.S. Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session September 29, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting September 28, 2022 From Glaukos Corporation Via Business Wire Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary September 07, 2022 Via Benzinga Dow Jumps 450 Points; UiPath Shares Slide September 07, 2022 U.S. stocks traded higher toward the end of trading, with the Dow Jones adding around 450 points on Wednesday. Via Benzinga Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday September 08, 2022 Gainers Via Benzinga Dow Up 249 Points, Nasdaq Set To Snap Skid September 07, 2022 Stocks are charging higher this afternoon, though investors are still awaiting the release of the Federal Reserve's Beige Book. Via Talk Markets Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session September 07, 2022 Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy. Via Benzinga Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday September 07, 2022 Via Benzinga What's Going On With Glaukos Shares? September 07, 2022 Glaukos Corp (NYSE: GKOS) shares are trading higher by 1.87% to $49.00 Wednesday morning after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved... Via Benzinga Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles September 07, 2022 From Glaukos Corporation Via Business Wire Glaukos Announces More Than 1 Million iStent® Technologies Implanted Worldwide September 06, 2022 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in the Wells Fargo Healthcare Conference August 24, 2022 From Glaukos Corporation Via Business Wire Glaukos Stock Scores Rising Price Performance With Jump To 91 RS Rating August 16, 2022 On Tuesday, Glaukos stock hit an key technical milestone, with its Relative Strength Rating climbing to 91, up from 87 the day before. Via Investor's Business Daily Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary August 03, 2022 Via Benzinga Glaukos: Q2 Earnings Insights August 03, 2022 Glaukos (NYSE:GKOS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Glaukos missed estimated earnings by... Via Benzinga Glaukos Announces FDA 510(k) Clearance of iStent infinite® August 03, 2022 From Glaukos Corporation Via Business Wire Glaukos Corporation Announces Second Quarter 2022 Financial Results August 03, 2022 From Glaukos Corporation Via Business Wire Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3 July 13, 2022 From Glaukos Corporation Via Business Wire The 6 Most Aggressive Growth Stocks to Buy in July July 12, 2022 These are the 6 most aggressive growth stocks to buy in July. They reflect huge potential growth in their sales and/or their earnings. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.